BLOOD SYSTEMS INC has a total of 16 patent applications. Its first patent ever was published in 1987. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are NHS BLOOD & TRANSPLANT, SUZHOU GENEPHARMA CO LTD and JIANGSU MICROMEDMARK BIOTECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | United States | 4 | |
#4 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Measuring microorganism processes | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Medical preparations | |
#6 | Enzymes | |
#7 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Delwart Eric | 10 |
#2 | Kapoor Amit | 9 |
#3 | Smith Kenneth J | 3 |
#4 | Li Linlin | 3 |
#5 | Victoria Joseph | 2 |
#6 | Montalvo Leilani | 2 |
#7 | Wen Li | 2 |
#8 | Lee Tzong-Hae | 2 |
#9 | Ndhlovu Lishomwa | 1 |
#10 | Chavez Leonard | 1 |
Publication | Filing date | Title |
---|---|---|
US2018153901A1 | Reversal of latency of retroviruses with a galectin protein | |
EP2528931A2 | Cyclovirus and method of use | |
WO2011049835A1 | Human parvovirus: humink parvovirus | |
EP2467393A1 | New astrovirus species | |
WO2010039987A1 | Reagent for elimination of red blood cells and hemoglobin in a sample | |
WO2009146210A2 | New human parvovirus: bocavirus | |
WO2009117615A2 | Novel divergent picornavirus:cosavirus | |
US4786726A | Factor IX therapeutic blood product, means and methods of preparing same | |
EP0229026A2 | Therapeutic blood product, means and methods of preparing same |